Part D Plans Need Mandatory Generic Programs Without Carve-Outs – GPhA
The Centers for Medicare & Medicaid Services should require Medicare prescription drug plans to implement mandatory generic drug substitution programs that do not contain "carve-outs" for certain classes of brand drugs, the Generic Pharmaceutical Association said
You may also be interested in...
U.S. Pharmacopeia's model drug classification system is only a "starting point" in developing a Medicare formulary that will pass muster with the Centers for Medicare & Medicaid Services
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials